Brazilian evidence-based guideline for screening, diagnosis, treatment, and follow-up of metabolic dysfunction-associated steatotic liver disease (MASLD) in adult individuals with overweight or obesity: A joint position statement from the Brazilian Society of Endocrinology and Metabolism (SBEM), Brazilian Society of Hepatology (SBH), and Brazilian Association for the Study of Obesity and Metabolic Syndrome (Abeso)

ABSTRACT Introduction: Metabolic dysfunction-associated steatotic liver disease (MASLD), previously known as Nonalcoholic fatty liver disease (NAFLD), is one of the most common hepatic diseases in individuals with overweight or obesity. In this context, a panel of experts from three medical societi...

Full description

Bibliographic Details
Main Authors:	Rodrigo Oliveira Moreira, Cynthia Melissa Valerio, Cristiane Alves Villela-Nogueira, Cintia Cercato, Fernando Gerchman, Ana Maria Pita Lottenberg, Amélio Fernando Godoy-Matos, Ricardo de Andrade Oliveira, Carlos Eduardo Brandão Mello, Mário Reis Álvares-da-Silva, Nathalie Carvalho Leite, Helma Pinchemel Cotrim, Edison Roberto Parisi, Giovanni Faria Silva, Paulo Augusto Carvalho Miranda, Bruno Halpern, Claudia Pinto Oliveira
Format:	Article
Language:	English
Published:	Brazilian Society of Endocrinology and Metabolism 2023-12-01
Series:	Archives of Endocrinology and Metabolism
Subjects:	Clinical guidelines overweight obesity non-alcoholic fatty liver disease metabolic dysfunction-associated steatotic liver disease
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S2359-39972023000601000&lng=en&tlng=en

Internet

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S2359-39972023000601000&lng=en&tlng=en

Internet

Similar Items